Literature DB >> 28808834

Biochemical and behavioral phenotype of AGAT and GAMT deficient mice following long-term Creatine monohydrate supplementation.

Furhan Iqbal1,2, Herald Hoeger3, Gurt Lubec4, Olaf Bodamer5.   

Abstract

The creatine/phosphocreatine system is essential for cellular phosphate coupled energy storage and production. We investigated the utility of creatine monohydrate supplementation in two different creatine deficient knockout mouse models. Following weaning, female Arginine: Glycine Amidinotransferase (AGAT) and Guanidinoacetate: methyltransferase (GAMT) knockouts and wild type mice were studied based on their genotypes and dietary supplementation (creatine free or 2% creatine monohydrate supplemented diet) for 10 weeks, using a series of behavioral tests and biochemical analyzes. An improved Rota rod performance was observed in both AGAT (p = 0.02) and GAMT knockout mice (p < 0.001) supplemented with 2% creatine. During Morris water maze probe trial, creatine supplemented AGAT knockout mice took less time to reach virtual platform (p = 0.03) and more frequently crossed this area (p = 0.001) than mice on creatine free diet. Similar observations were recorded for GAMT knockout mice. Urinary creatinine concentrations for AGAT (p = 0.001) and GAMT (p = 0.05) knockout mice were increased following creatine supplementation. Creatine supplementation has a potential to improve neuro-muscular coordination, spatial learning in both AGAT and GAMT knockout mice. Long term Creatine supplementation results in increased urine creatinine concentrations indicating improved creatine metabolism in knockout mice.

Entities:  

Keywords:  AGAT; Behavior; Biochemical profile; Creatine monohydrate; GAMT; Knockout mouse

Mesh:

Substances:

Year:  2017        PMID: 28808834     DOI: 10.1007/s11011-017-0092-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  34 in total

1.  Memory training alters hippocampal neurochemistry in healthy elderly.

Authors:  Michael J Valenzuela; Megan Jones; Wei Wen; Caroline Rae; Scott Graham; Ronald Shnier; Perminder Sachdev
Journal:  Neuroreport       Date:  2003-07-18       Impact factor: 1.837

2.  Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis.

Authors:  S Stöckler; B Marescau; P P De Deyn; J M Trijbels; F Hanefeld
Journal:  Metabolism       Date:  1997-10       Impact factor: 8.694

3.  Labile methyl group balances in the human: the role of sarcosine.

Authors:  S H Mudd; M H Ebert; C R Scriver
Journal:  Metabolism       Date:  1980-08       Impact factor: 8.694

4.  L-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome.

Authors:  Chi-un Choe; Christine Nabuurs; Malte C Stockebrand; Axel Neu; Patricia Nunes; Fabio Morellini; Kathrin Sauter; Stefan Schillemeit; Irm Hermans-Borgmeyer; Bart Marescau; Arend Heerschap; Dirk Isbrandt
Journal:  Hum Mol Genet       Date:  2012-10-01       Impact factor: 6.150

5.  Biochemical and behavioural phenotyping of a mouse model for GAMT deficiency.

Authors:  An Torremans; Bart Marescau; Ilse Possemiers; Debby Van Dam; Rudi D'Hooge; Dirk Isbrandt; Peter Paul De Deyn
Journal:  J Neurol Sci       Date:  2005-04-15       Impact factor: 3.181

6.  Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis.

Authors:  A Humm; E Fritsche; S Steinbacher; R Huber
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

7.  Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation.

Authors:  Airi Watanabe; Nobumasa Kato; Tadafumi Kato
Journal:  Neurosci Res       Date:  2002-04       Impact factor: 3.304

8.  Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?

Authors:  K M Cecil; G S Salomons; W S Ball; B Wong; G Chuck; N M Verhoeven; C Jakobs; T J DeGrauw
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

9.  Effects of dietary creatine supplementation for 8 weeks on neuromuscular coordination and learning in male albino mouse following neonatal hypoxic ischemic insult.

Authors:  Shahid Iqbal; Muhammad Ali; Atif Akbar; Furhan Iqbal
Journal:  Neurol Sci       Date:  2014-12-16       Impact factor: 3.307

10.  Treatment monitoring of brain creatine deficiency syndromes: a 1H- and 31P-MR spectroscopy study.

Authors:  M C Bianchi; M Tosetti; R Battini; V Leuzzi; M G Alessandri'; C Carducci; I Antonozzi; G Cioni
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

View more
  4 in total

1.  Oral supplementation of Lanthanum Zirconate nanoparticles moderately affected behavior but drastically disturbed leukocyte count, serum cholesterol levels and antioxidant parameters from vital organs of albino mice in a gender specific manner.

Authors:  Muhammad Nazar Aftab; Irum Naz Akram; Tafheem Khosa; Syeda Qandeel Zahra; Irum Bashir; Muhammad Naeem Ashiq; Furhan Iqbal
Journal:  Metab Brain Dis       Date:  2018-05-21       Impact factor: 3.584

Review 2.  Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency.

Authors:  Luigia Rossi; Francesca Nardecchia; Francesca Pierigè; Rossella Ventura; Claudia Carducci; Vincenzo Leuzzi; Mauro Magnani; Simona Cabib; Tiziana Pascucci
Journal:  Genes (Basel)       Date:  2021-08-02       Impact factor: 4.096

3.  Preconditioning beef cattle for long-duration transportation stress with rumen-protected methionine supplementation: A nutrigenetics study.

Authors:  Gastón F Alfaro; Taylor E Novak; Soren P Rodning; Sonia J Moisá
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

4.  Homoarginine- and Creatine-Dependent Gene Regulation in Murine Brains with l-Arginine:Glycine Amidinotransferase Deficiency.

Authors:  Märit Jensen; Christian Müller; Edzard Schwedhelm; Priyadharshini Arunachalam; Mathias Gelderblom; Tim Magnus; Christian Gerloff; Tanja Zeller; Chi-Un Choe
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.